Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors
Year: 2011
Type: review
Source: Current Opinion in Microbiology
Author: Ken Coleman
Institution: Arietis (United States)
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Sanofi
OpenAlex ID: W2045211463
